Thomson Pharma Enhanced with Global Regulatory Intelligence

Jul 07, 2006


      Bookmark and Share

Thomson Scientific, a business of The Thomson Corporation, has announced a new enhancement to Thomson Pharma--a drug discovery and development information solution designed to fulfill the information needs of professionals working at all stages of the drug development pipeline. The new Thomson Pharma Regulatory Affairs Module provides regulatory, legal, and scientific information for development and registration of medicinal products and biologics. The Regulatory Affairs Module is derived from IDRAC, a global regulatory intelligence database that brings together information on regulatory requirements from 140 different sources, including 70 authorities.

As part of the content of Thomson Pharma, the Regulatory Affairs Module provides professionals at different stages of drug development with information needed to make decisions in: Regulatory Intelligence; Regulatory Affairs; Clinical Research; Quality Assurance; Strategic Marketing; Pharmacovigilance, and Risk Management.

(www.thomsonpharma.com; www.thomson.com)